Trump's safety research cuts heighten workplace risks, federal workers warn
Drastic cuts at a federal workplace safety research agency increase the risk of illness and injury for workers across the US and undermine preparations for public health emergencies, fired employees warn.
The Trump administration ordered widespread layoffs at the National Institute for Occupational Safety and Health, inside the Centers for Disease Control and Prevention, when it issued a 'reduction in force' notice to some 85% of the agency's 1,100 workers employees on 1 April.
While some of those terminations were later reversed following pushback from labor unions and the public, only 328 employees were reinstated.
'An immediate impact is that we're not as prepared for some type of public health emergency,' said Dr Micah Niemeier-Walsh, an industrial hygienist at NIOSH in Ohio, who was fired, and then reinstated. 'Long term, the Trump administration talks about wanting to bring back or expand certain sectors of the economy like mining or manufacturing. Those are jobs that really rely on NIOSH work.'
Jennica Bellanca, for example, worked to train emergency responders in mining in Pittsburgh, Pennsylvania. Her role was terminated.
'It's such a hard thing. Everyone here works so hard to help support the health and safety of mine workers and other workers,' she said, noting that small companies do not have the resources to invest in alternative safety programs. 'I'm just concerned that nobody else is going to fill this gap. There's a reason that the government provides this safety net.
'In our case, the safety net is to help workers go home to their families every day and make sure that nothing bad happens.'
Bellanca questioned a central argument for the cuts – efficiency in federal government spending – by noting that long-term research projects may now go unreleased.
'When we're gone, there's going to be nobody to get this information out,' she said. 'And because we were so abruptly, sort of cut off in the middle of projects, all of this work that we've done, we're not able to get this out, released, as a full public product. In my mind, that's a waste of government money.'
Niemeier-Walsh, the vice-president of American Federal of Government Employees Local 3840, said the reduction in force was the 'final, massive blow to our work' after earlier limitations on travel, communications and remote work imposed since Donald Trump took office in January.
'Our ability to be as successful as we have been as an institute relies on the rest of the NIOSH employees coming back because our work is so interconnected,' said Niemeier-Walsh. 'I'm very, very concerned what this means for every single American worker if we're not able to fully restore NIOSH. These cuts are not based in science. They're not based on the public health need. They're based on politics, and that's bad for the health of the American people.'
She cited as an example the employees in the health hazard evaluation program, which was established to reduce workplace risks and recommend ways to mitigate dangers, who were reinstated after earlier cuts. But they rely on chemists to develop analytical methods to measure chemicals in the workplace, and engineers to design solutions; these chemists and engineers have not been reinstated, she said.
Since the agency was founded in 1970, recordable workplace illnesses and injuries and fatalities have been drastically reduced in the US. The rate of nonfatal workplace injuries and illnesses declined from 10.9 cases per 100 full-time workers in 1972 to 2.4 in 2023.
The AFL-CIO, the largest federation of labor unions in the US, and several other labor unions filed a lawsuit this month to restore the cut programs at NIOSH, arguing the cuts 'directly threaten the lives of workers whose safety and health depend on NIOSH' services that are congressionally mandated.
Even though some of the initial cuts have been reversed,'we have deep concerns that the whole reason NIOSH was started to begin with is still eliminated,' said Rebecca Reindel, the director of occupational safety and health at the AFL-CIO, who noted that the agency's founding mandate was to assure every man and woman in the US has safe and healthful working conditions.
Reindel expressed particular concern about disruption to long-term research projects.
'All of this research work that they do, where they have these big cohorts, they've been following people for 40 years,' she said. 'And now they're just cut off for these occupational prospective cohorts, where they follow them over years to see what kind of diseases are developing.
'If we're just staffing those cohorts now, we're really losing 40 years worth of work. Even if they restart them, we're going to have lost so many people to follow up,.'
A spokesperson for the Department of Health and Human Services did not comment on the record. Its secretary, Robert F Kennedy Jr, is working to ensure NIOSH critical services remain intact and continue as the agency streamlines its operations, they claimed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
15 minutes ago
- Reuters
Breakdown of U.S. tariffs on China since Trump's first term
BEIJING, June 12 (Reuters) - Billions of dollars of Chinese goods have been impacted by additional U.S. tariffs since 2018, initially under the first Donald Trump presidency and later under the Biden administration. Returning to the White House this year, Trump has imposed even more duties on China. The U.S. tariffs range from those imposed under Section 301 of its trade act due to what Washington claims are unfair Chinese trade practices, to duties under Section 232 levied for national security reasons. This year, Trump has imposed another 20% levies on all Chinese goods, saying Beijing has not done enough to stop the flow of fentanyl into the United States. So-called reciprocal tariffs, under which the U.S. will match duties imposed by other countries, have also been levied in a bid to rebalance trade flows. Below are the U.S. tariffs on China effective as of June 12, 2025: In September 2019, the U.S. imposed 15% tariffs on more than $120 billion of Chinese goods under Section 301, which it then halved to 7.5% less than six months later. The 25% U.S. tariffs on $250 billion of Chinese goods under the earlier List 1-3 remain unchanged. In September 2024, the U.S. Trade Representative under the Biden administration announced additional tariffs of 25-100% on 14 product groups following a four-year review of the Section 301 tariff actions. The levies were imposed on strategic Chinese sectors or sectors where the United States has made significant domestic investments. In addition to the above duties, the first Trump administration in 2018 imposed a range of tariffs under Section 232 aimed at restricting goods deemed a threat to national security, including all aluminium and steel imports, shutting most Chinese suppliers out of the U.S. market.
Telegraph
26 minutes ago
- Telegraph
Trump wants to sell America to China – but will they buy?
On Wednesday, a jubilant Donald Trump declared that his trade deal with Beijing would 'open up China to American Trade', delivering 'a great WIN for both countries!!!' Yet even as the US president trumpets victory, a chorus of Western companies has been warning that the spoils may be underwhelming. Cosmetics company Estee Lauder is grappling with 'retail softness, reflecting subdued consumer sentiment' in China. Drinks giant Diageo, which makes Guinness and Johnnie Walker, said 'consumers remain cautious and the macroeconomic recovery is taking longer than expected'. Unilever, the consumer goods giant behind Dove soap and Ben & Jerry's ice cream, told its shareholders that 'market growth in China remained subdued'. Burberry reported waning sales there, while KFC and Pizza Hut-owner Yum China said sales in the first quarter were flat. When Starbucks this week slashed the price of its tea lattes and Frappuccinos in China by almost one fifth, it was only the latest sign that trouble was brewing in China for big Western businesses. Trump wants Chinese consumers to buy more American goods, rebalancing what he sees as the lopsided trading relationship between the two countries. But the middle kingdom's economy is in a prolonged funk, reeling from a property crisis and a long hangover from harsh Covid restrictions. With lingering US tariffs of up to 55pc taking a chunk out of China's exports, recovery in the world's second-largest economy depends on the willingness of Chinese consumers to open their wallets and start spending. But unless companies cut prices, or the government steps in to boost demand, cautious Chinese consumers are at best spending selectively. Unlike China's gleaming motorways, the road to an economic rebound looks slow and uncertain – meaning Trump may well be disappointed. Ending the US president's anti-China crusade depends on the Chinese consumer taking out their wallets. It's the 'excess savings' of China's households, coupled with the excess spending of the American government and consumers, that lie at the heart of the pair's unbalanced economic relationship. In layman's terms, Chinese families save, while Americans buy – meaning China exports to the US far more than it imports. 'China has a singular opportunity to stabilise its economy by shifting away from excess production towards greater consumption,' Scott Bessent, the US treasury secretary, said on Wednesday. So far, there is little sign of the balance shifting. In a recent survey by McKinsey, Chinese households said they were not planning to increase how much they spend as a share of their income. (McKinsey saw this as progress; in the 2024 version of the survey, households had actually been planning to reduce consumption.) The survey found that rural dwellers were slightly more enthusiastic about shopping than their urban counterparts. That's unsurprising: it's in the cities where the scars of the property crisis, which began with the collapse of the developer Evergrande in 2021, are most acute. 'Property prices have fallen by around 20pc since the onset of the property crisis,' says Leah Fahy, a China analyst at Capital Economics. 'That has been a massive hit to household wealth and really dampened propensity to spend, and confidence as well.' 'And then more recently, you add all this tension around the trade war, what's going to happen with US tariffs. Even if the actual hit from that hasn't been massive yet.' Justin Koh, a Shanghai-based director at consultancy AlixPartners, says: 'When I first came to China about 15 years ago, there used to be an idea that everything would only go in one direction – up. People just thought sales would double every year. 'Now, the consumer companies we're working with are more pragmatic about growth. They're also very pragmatic about opening and closing stores, about what works and what doesn't work in the market.' Officially, China's economy is holding up, growing at 5.4pc in the first quarter from a year earlier. But the threat of a trade war looms over a country that still relies heavily on manufacturing. Exports to the US slumped by almost 35pc in April from a year earlier and China is struggling with deflation. Consumer prices dipped 0.1pc, the fourth consecutive month of decline, led by food and fuel. A survey by the EU Chamber of Commerce in China found that 83pc of food and beverage companies felt their business environment in the country was deteriorating. Many consumers seem to be looking for bargains, waiting for price decreases, or keeping their yuan in the bank or under the bed. Beijing has been encouraging people to spend, pushing them to buy more white goods by backing a trade-in scheme. It seems to have worked: according to the Xinhua news agency, it spurred 175bn renminbi (£18bn) of transactions this year, and 39pc year–on-year sales growth in April. But that would only be a drop in the ocean of what is required. It might stack a percentage point or two on to GDP growth, but Capital Economics reckons consumption might need to expand by 4pc to offset the hit from falling exports. Fahy says the government seems reluctant to wheel out the fiscal artillery needed to deliver this. 'You get a lot of lip service to the importance of supporting consumption, supporting demand, but they're really hesitant to expand things like social security measures, pension payments, welfare benefits – the things that are most needed to boost households' willingness to spend really and lower the savings rate,' she says. Worryingly for Trump, even if there is an upturn in consumer spending, Chinese may not choose to buy American products. 'There was probably more bargain hunting back in 2022, 2023 – confidence was lower, there was a very clear dip,' says Koh. 'I think this bargain-hunting helped consumers understand other [non-Western] brands a little bit better – they realised that, 'Hey, there might not be that much of a difference there.'' Chinese business news site Caixin says there has been an increase in promotions for 'repatriated foreign trade products' – items originally made to sell overseas that are now being sold at home. This includes marketing campaigns and exhibitions at supermarkets, department stores and shopping malls. Local brands are also gaining ground. Koh's 10-year-old daughter is wild for the Labubu dolls made by Chinese start-up Pop Mart, for example. 'They're the latest craze. If consumer confidence was at an all-time low, we'd likely be seeing less people buying them – less of that type of consumer behaviour,' he says. 'It's a sign of a more discerning consumer, and a consumer that's expressing his or her consumer confidence in different ways.' The ball is now in Beijing's court: the government needs to do more if it wants a consumer-led kickstart for the economy, and a fix for the US-China trade imbalances. Without action, Trump's 'great WIN' may turn into a disappointing loss.
Daily Mail
an hour ago
- Daily Mail
EXCLUSIVE I'm suffering from 'Ozempic penis', the latest bizarre side effect caused by weight loss drugs
Gaining inches on Ozempic isn't what dieters want to experience. That is, unless, the growth is occurring below the belt. An increase in penis size isn't something advertised as a side effect of semaglutide and similar medications, but anecdotally it seems to occur. Taking to Reddit, a fleet of male dieters have revealed how their penises seem to have grown after taking popular weight-loss medications like Wegovy and Ozempic. In a thread on the anonymous posting site, one Redditor said that after three months on Ozempic, he lost a 'fair bit of weight' and now, his 'junk definitely looks longer.' Asking if any other men had experienced the same phenomenon, many said they had. While there is no evidence weight-loss medications increase length or girth of the penis, it could appear larger because of the loss of fat around the bladder area. Improved heart health and blood flow after losing weight can also lead to stronger erections, making the penis appear longer and thicker. Another commenter on the thread, titled 'So ummmm that's an unexpected benefit,' wrote: 'I used to joke with my wife that this was bulls*** "because we would've noticed two extra inches!" Turns out I did get it. It's when I'm flaccid. 'I was already pleased with what I had to work with, but that was definitely a nice, if surprising, confidence boost.' In another thread, one man on weight loss drugs detailed a similar story. He explained: 'I've lost about 60lbs in four months so far. The wife today told me that she thinks my penis is larger from the meds. Could it be some unseen side effect?' In response, one female Redditor chimed in, writing: 'It does get bigger/more hard with weight loss. I can confirm this with my own husband's weight loss.' However, many commenters say this phenomenon is not to do with the Ozempic and it is a common thing that happens with losing lots of weight on or off the drugs. About 12 percent of US adults (31 million) have used a GLP-1 medication to lose weight, with around a quarter of this number being men. One commenter revealed their hypothesis, writing: 'It's the weight loss around the pubic area. 'It just looks bigger - which doesn't suck - and probably works better.' Offering a similar explanation, another Redditor said: 'That's pretty common when a guy loses weight. My partner lost about 120lbs or so and his definitely looks larger now. 'I don't think it actually does get larger, but losing fat around it gives it the appearance of being larger.' Dr Kenneth Lipman, an expert in integrative health, told losing weight around the belly area is what makes the penis looks bigger. It isn't actually growth resulting from the active ingredients in GLP-1 medications. He said: 'Globally, average penis size has been trending upward for years, and Ozempic is now getting some of the credit - deserved or not. 'What it does do is help men shed belly fat, which can reveal more of the penis. For some, it's the first time in years they've seen it without a mirror. 'On top of that, improved metabolic health - especially in men with diabetes - can enhance blood flow and lead to firmer, more robust erections, which can look and feel larger.' He added: 'Finally, consider that men just want bigger penises, and they may just be seeing what they want to see.' Research shows that the average size of an erect penis in the US has increased by about 24 percent over the past 29 years, from an average of 4.8 inches to 6 inches. And there are a number of penis lengthening procedures that people concerned about their manhood can opt for. One of these is surgery to cut the internal ligaments that support the penis in the body, moving a portion of it downwards to increase the length. Other techniques involve inserting a prosthetic to lengthen the penis. Penis filler has been another trend to swell over recent years, with men seeking to get filler injected into the penis, similar to women who get it injected into their lips or cheeks. While a larger penis is a benefit, people on Ozempic and similar drugs have reported less desirable side effects such as fatigue, abdominal cramps, vomiting, depression and a decreased libido.
